The prescriber has ordered filgrastim (granulocyte colony–stimulating factor) for a patient undergoing myelosuppressive chemotherapy. Which side effect should the nurse tell the patient that she may anticipate?
a. Bone pain
b. Fatigue
c. Bleeding
d. Headache
ANS: A
Filgrastim causes bone pain in about 25% of patients. The pain is dose related and usually mild to moderate.
Fatigue, bleeding, and headache are not side effects of filgrastim.
You might also like to view...
What should nursing care focus on to best support a patient with mild cognitive impairment (MCI)?
a. Reorienting the patient to the physical en-vironment b. Developing strategies to improve memory c. Assisting with dressing and eating d. Establishing toileting schedules
A nurse provides care in a large, urban hospital that serves a clientele of many different ethnicities and racial backgrounds. Which of the following statements is accurate regarding a patient's integumentary health?
A) Patients with darker skin have skin that is generally more resilient than that of lighter-skinned patients. B) Patients with darker skin are largely immune to ultraviolet damage but have an increased risk of skin infections. C) Patients with darker skin and patients with lighter skin have similar risks of most skin diseases. D) Patients with darker skin have higher incidence of most skin disorders, but these are usually more difficult to diagnose.
Complications of head injury may not be evident for up to
A. 2 hours. B. 8 hours. C. 24 hours. D. 72 hours.
What compatibility tests are performed to determine eligibility for transplantation and to
ensure as close a match as possible? What will be an ideal response?